Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Raniszewska (Warszawa, Poland), I. Kwiecien (Warszawa, Poland), E. Rutkowska (Warszawa, Poland), R. Sokolowski (Warszawa, Poland), J. Domagala-Kulawik (Warszawa, Poland). Immunomodulating properties of FasL+ lung cancer cells identified in lymph nodes aspirates of NSCLC patients. 1655

Member's Comments

No comment yet.

Related content which might interest you: Immunomodulating properties of PD-L1 positive cancer stem cells in metastatic lymph nodes Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer Year: 2019 PD-L1 expression on lung cancer stem cells in metastatic lymph nodes. Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management Year: 2018 T cell maturation profile in metastatic vs. non-metastatic lymph nodes in NSCLC patients Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Correlation between p53 expression in bronchus biopsies from non-small cell lung cancer cases and mediastinal lymph node invasion demonstrated through mediastinoscopy Source: Eur Respir J 2006; 28: Suppl. 50, 82s Year: 2006 Detection of lung cancer micrometastases in lymph nodes aspirates by flow cytometry. Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020 Lymph nodes frozen section in staging of non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 534s Year: 2005 An usual metastasis of squamous cell lung cancer: intra-abdominal lymph nodes Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009 Different morphological changes in non-small cell lung cancers and their corresponding lymph node metastases after neoadjuvant therapy? Source: Eur Respir J 2004; 24: Suppl. 48, 479s Year: 2004 Microbiological study of mediastinal lymph node biopsy from patients with sarcoidosis and lung cancer Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant. A prospective study Source: Eur Respir J 2007; 30: Suppl. 51, 206s Year: 2007 EpCAM-positive circulating cells in lung cancer patients Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 A study on the identification of the sentinel node in the lung cancer patients Source: Eur Respir J 2001; 18: Suppl. 33, 14s Year: 2001 Telomerase activity, micrometastasis and lynphonodal metastasis in resected non small cell lung cancer Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology Year: 2008 Evaluation of dendritic cells in peripheral blood and pleural effusion of non-small-cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 529s Year: 2004 EBUS-TBNA of lymph nodes in the radiologically and PET normal mediastinum in patients with lung cancer Source: Annual Congress 2008 - Ways into the mediastinum Year: 2008 High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodes Source: ERJ Open Res, 3 (2) 00110-2016; 10.1183/23120541.00110-2016 Year: 2017 Foxp3+ cells are running the show in patients with surgically resected nonsmall cell lung cancer Source: Eur Respir J 2015; 46: 1541-1543 Year: 2015 Role of molecular and cellular techniques applied to EBUS-TBNA of mediastinal lymph nodes for lung cancer staging Source: Annual Congress 2012 - EBUS-TBNA: a never ending story Year: 2012 Regulatory vs. cytotoxic cells in lymph nodes of lung cancer patients resected by TEMLA Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016